BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 16344462)

  • 1. Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element.
    Horikawa I; Chiang YJ; Patterson T; Feigenbaum L; Leem SH; Michishita E; Larionov V; Hodes RJ; Barrett JC
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18437-42. PubMed ID: 16344462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells.
    Takakura M; Kyo S; Inoue M; Wright WE; Shay JW
    Mol Cell Biol; 2005 Sep; 25(18):8037-43. PubMed ID: 16135795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proximal promoter region of mTert is sufficient to regulate telomerase activity in ES cells and transgenic animals.
    Pericuesta E; Ramírez MA; Villa-Diaz A; Relaño-Gines A; Torres JM; Nieto M; Pintado B; Gutiérrez-Adán A
    Reprod Biol Endocrinol; 2006 Feb; 4():5. PubMed ID: 16457732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.
    Günes C; Lichtsteiner S; Vasserot AP; Englert C
    Cancer Res; 2000 Apr; 60(8):2116-21. PubMed ID: 10786671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT.
    Fujimoto K; Kyo S; Takakura M; Kanaya T; Kitagawa Y; Itoh H; Takahashi M; Inoue M
    Nucleic Acids Res; 2000 Jul; 28(13):2557-62. PubMed ID: 10871406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
    Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
    Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression.
    Horikawa I; Cable PL; Mazur SJ; Appella E; Afshari CA; Barrett JC
    Mol Biol Cell; 2002 Aug; 13(8):2585-97. PubMed ID: 12181331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomeric function of mammalian telomerases at short telomeres.
    Fakhoury J; Marie-Egyptienne DT; Londoño-Vallejo JA; Autexier C
    J Cell Sci; 2010 May; 123(Pt 10):1693-704. PubMed ID: 20427319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes.
    Cheng D; Zhao Y; Wang S; Zhang F; Russo M; McMahon SB; Zhu J
    FASEB J; 2017 Mar; 31(3):1165-1178. PubMed ID: 27940549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT; Yang HT; Wang TC; Cheng AJ
    Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
    Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer.
    Lee SH; Kim JW; Oh SH; Kim YJ; Rho SB; Park K; Park KL; Lee JH
    FEBS Lett; 2005 Feb; 579(5):1027-33. PubMed ID: 15710386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation.
    Greenberg RA; Allsopp RC; Chin L; Morin GB; DePinho RA
    Oncogene; 1998 Apr; 16(13):1723-30. PubMed ID: 9582020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chromosome 5 carries a transcriptional regulator of human telomerase reverse transcriptase (hTERT).
    Qi DL; Ohhira T; Oshimura M; Kugoh H
    Biochem Biophys Res Commun; 2010 Aug; 398(4):695-701. PubMed ID: 20621064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F-1 represses transcription of the human telomerase reverse transcriptase gene.
    Crowe DL; Nguyen DC; Tsang KJ; Kyo S
    Nucleic Acids Res; 2001 Jul; 29(13):2789-94. PubMed ID: 11433024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A BAC transgenic reporter recapitulates in vivo regulation of human telomerase reverse transcriptase in development and tumorigenesis.
    Jia W; Wang S; Horner JW; Wang N; Wang H; Gunther EJ; DePinho RA; Zhu J
    FASEB J; 2011 Mar; 25(3):979-89. PubMed ID: 21135040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
    He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
    Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
    Song Y; Kong BH; Liu PS; Ma DX; Jiang S
    Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
    Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
    Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.